Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Health Aff (Millwood). 2021 Sep;40(9):1440–1448. doi: 10.1377/hlthaff.2021.00546

EXHIBIT 3:

Predicted means and probabilities of chronic conditions among enrollees in US commercial insurance plans, by transgender status, weighted, 2001–19

Transgender Cisgender
Total morbidity score (mean) 3.00 1.99
Cardiovascular conditions (%)
 Hypertension 27.27 32.64
 Cardiac arrhythmia 17.25 12.56
 Valvular disease 8.96 7.50
 Peripheral vascular disorders 7.31 8.06
 Congestive heart failurea 4.95 3.68
 Coagulopathy 4.44 3.03
 Pulmonary circulation disorders 2.88 2.24
Neurological conditions (%)
 Other neurological disorders 8.09 5.34
 Paralysis 1.30 0.97
Weight, diabetic, and thyroid conditions (%)
 Obesity 21.87 15.62
 Fluid and electrolyte disorders 15.54 10.16
 Hypothyroidism 19.13 12.90
 Diabetes 12.88 13.90
 Abnormal weight loss 7.80 4.35
Mental health and substance use (%)
 Depression 56.46 19.86
 Drug use disorder 8.12 3.21
 Psychoses 5.81 1.44
 Alcohol use disordera 5.25 3.20
Other chronic conditions (%)
 Chronic pulmonary disease 26.29 18.13
 Blood loss or deficiency anemia 10.75 6.54
 Liver diseasea 9.22 5.97
 Renal failurea 5.61 4.06
 Rheumatoid arthritis/collagen 7.88 5.30
 Cancerb 5.12 5.05
 AIDS/HIV 1.51 0.29
 Peptic ulcer disease excluding bleeding 2.13 1.25

source Authors’ analysis derived from administrative data from Optum’s Clinformatics Data Mart Database, 2001–19. notes The data source included deidentified insurance claims for privately insured and Medicare Advantage enrollees. Total morbidity score was determined using the Elixhauser Comorbidity Index. The underlying transgender numbers vary as a result of our transgender identification criteria, as some chronic condition and transgender exclusion codes overlap with those of the Elixhauser Comorbidity Index. So as to not bias our estimates downward, we removed people from our calculations who were identified as transgender only because they fell into an inclusion category that required that they did not have the condition being analyzed. See Jasuja GK, et al., note 3 in text, for more detail. Sample sizes are in exhibit 1 except where noted. p < 0.001 for all variables.

a

Transgender n = 35,631.

b

Transgender n = 31,124.